ESR1 and breast cancer: For example, melatonin can cause receptor-mediated inhibition of cyclic adenosine monophosphate (cAMP), resulting in downregulation of the transcriptional expression of ERα in human breast cancer cells and lower fatty acid metabolism by tumour cells through decreased fatty acid transport [39, 47, 49].